Popular Breast Cancer Drugs Negatively Affects Sex Life, Orebro University and Uppsala Universitet Study

Published: Oct 01, 2012

Postmenopausal women treated for breast cancer with drugs known as aromatase inhibitors have high rates of sexual problems, which is an important and underestimated issue, according to a new study from Sweden. Nearly three-quarters of these women reported insufficient lubrication, 56 percent had pain during intercourse, half said their sexual interest was low, and 42 percent were dissatisfied with their sex life.

Back to news